Neuroprotective effects of bisperoxovanadium on cerebral ischemia by inflammation inhibition

Neuroscience Letters

Volumn 602, Issue , 2015, Pages 120-125

  Mao, Lun Lin ^a   Hao, Dong Lin ^a   Mao, Xiao Wei ^b   Xu, Yuan Feng ^a   Huang, Ting Ting ^a   Wu, Bo Na ^a   Wang, Li Hui ^a  

^a Wujin Hospital Affiliated with Jiangsu University   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

(GSK 3 ); Akt; Bisperoxovanadium (Bpv); Glycogen synthase kinase 3 ; Ischemic stroke; Middle cerebral artery occlusion (MCAO); Phosphatidylinositol 3 kinase (PI3K)

Indexed keywords

BISPEROXOVANADIUM; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 10; MESSENGER RNA; NEUROPROTECTIVE AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, RAT; VANADIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; INVESTIGATIVE PROCEDURES; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN INFARCTION; DRUG EFFECTS; INFLAMMATION; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; STROKE;

ANIMALS; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBRAL CORTEX; GLYCOGEN SYNTHASE KINASE 3; INFLAMMATION; INTERLEUKIN-10; MALE; NEUROPROTECTIVE AGENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STROKE; TUMOR NECROSIS FACTOR-ALPHA; VANADIUM COMPOUNDS;

EID: 84937032147     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.06.040     Document Type: Article

References (29)

1. Kirshner H.S. Differentiating ischemic stroke subtypes: risk factors and secondary prevention. J. Neurol. Sci. 2009, 279:1-8.
2. Lo E.H., Dalkara T., Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 2003, 4:399-415.
3. Xing C., Arai K., Lo E.H., Hommel M. Pathophysiologic cascades in ischemic stroke. Int. J. Stroke. 2012, 7:378-385.
4. Eltzschig H.K., Eckle T. Ischemia and reperfusion-from mechanism to translation. Nat. Med. 2011, 17:1391-1401.
5. Shichita T., Ito M., Yoshimura A. Post-ischemic inflammation regulates neural damage and protection. Front. Cell. Neurosci. 2014, 8:319.
6. Broughton B.R., Reutens D.C., Sobey C.G. Apoptotic mechanisms after cerebral ischemia. Stroke 2009, 40:e331-e339.
7. Zhu Y., Hoell P., Ahlemeyer B., Sure U., Bertalanffy H., Krieglstein J. Implication of PTEN in production of reactive oxygen species and neuronal death in in vitro models of stroke and Parkinson's disease. Neurochem. Int. 2007, 50:507-516.
8. Li X., Zhang J., Chai S., Wang X. Progesterone alleviates hypoxic-ischemic brain injury via the Akt/GSK-3β signaling pathway. Exp. Ther. Med. 2014, 8:1241-1246.
9. Xu L., Li Y., Fu Q., Ma S. Perillaldehyde attenuates cerebral ischemia-reperfusion injury-triggered overexpression of inflammatory cytokines via modulating Akt/JNK pathway in the rat brain cortex. Biochem. Biophys. Res. Commun. 2014, 454:65-70.
10. Hanumanthappa P., Densi A., Krishnamurthy R.G. Glycogen synthase kinase-β3 in ischemic neuronal death. Curr. Neurovasc. Res. 2014, 11:271-278.
11. Shi G.D., OuYang Y.P., Shi J.G., Liu Y., Yuan W., Jia L.S. PTEN deletion prevents ischemic brain injury by activating the mTOR signaling pathway. Biochem. Biophys. Res. Commun. 2011, 404:941-945.
12. Sun J., Tong L., Luan Q., Deng J., Li Y., Li Z., Dong H., Xiong L. Protective effect of delayed remote limb ischemic postconditioning: role of mitochondrial K(ATP) channels in a rat model of focal cerebral ischemic reperfusion injury. J. Cereb. Blood. Flow. Metab. 2012, 32:851-859.
13. Mao L., Jia J., Zhou X., Xiao Y., Wang Y., Mao X., Zhen X., Guan Y., Alkayed N.J., Cheng J. Delayed administration of a PTEN inhibitor BPV improves functional recovery after experimental stroke. Neuroscience 2013, 231:272-281.
14. Hossmann K.A. Cerebral ischemia: models, methods and outcomes. Neuropharmacology 2008, 55:257-270.
15. Nakka V.P., Gusain A., Mehta S.L., Raghubir R. Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities. Mol. Neurobiol. 2008, 37:7-38.
16. Schmid A.C., Byrne R.D., Vilar R., Woscholski R. Bisperoxovanadium compounds are potent PTEN inhibitors. FEBS Lett. 2004, 566:35-38.
17. Guo J.Y., Ding J., Yuan F., Chen H., Chen S.W., Tian H.L. Dose-Dependent protective effect of bisperoxovanadium against acute cerebral ischemia in a rat model of ischemia/reperfusion injury. Int. J. Mol. Sci. 2013, 14:12013-12022.
18. Zhao J., Qu Y., Wu J., Cao M., Ferriero D.M., Zhang L., Mu D. PTEN inhibition prevents rat cortical neuron injury after hypoxia-ischemia. Neuroscience 2013, 238:242-251.
19. Grande V., Manassero G., Vercelli A. Neuroprotective and anti-inflammatory roles of the phosphatase and tensin homolog deleted on chromosome Ten (PTEN) Inhibition in a Mouse Model of Temporal Lobe Epilepsy. PLoS One 2014, 9:e114554.
20. Tobin M.K., Bonds J.A., Minshall R.D., Pelligrino D.A., Testai F.D., Lazarov O. Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here. J. Cereb. Blood. Flow. Metab. 2014, 34:1573-1584.
21. Lambertsen K.L., Biber K., Finsen B. Inflammatory cytokines in experimental and human stroke. J. Cereb. Blood Flow Metab. 2012, 32:1677-1698.
22. T. Dziedzic, Systemic inflammation as a therapeutic target in acute ischemic stroke, Expert. Rev. Neurother. 2015 Apr 12:1-9. [Epub ahead of print].
23. Zaremba J., Losy J. Early TNF-alpha levels correlate with ischaemic stroke severity. Acta. Neurol. Scand. 2001, 104:288-295.
24. Vila N., Castillo J., Dávalos A., Esteve A., Planas A.M., Chamorro A. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke 2003, 34:671-675.
25. Liesz A., Bauer A., Hoheisel J.D., Veltkamp R. Intracerebral interleukin-10 injection modulates post-ischemic neuroinflammation: an experimental microarray study. Neurosci. Lett. 2014, 579:18-23.
26. Parajuli N., Yuan Y., Zheng X., Bedja D., Cai Z.P. Phosphatase PTEN is critically involved in post-myocardial infarction remodeling through the Akt/interleukin-10 signaling pathway. Basic. Res. Cardiol. 2012, 107:248.
27. Yue S., Rao J., Zhu J., Busuttil R.W., Kupiec-Weglinski J.W., Lu L., Wang X., Zhai Y. Myeloid PTEN deficiency protects livers from ischemia reperfusion injury by facilitating M2 macrophage differentiation. J. Immunol. 2014, 192:5343-5353.
28. Sharma S., Yang B., Xi X., Grotta J.C., Aronowski J., Savitz S.I. IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways. Brain. Res. 2011, 1373:189-194.
29. Song W.J., Song E.A., Jung M.S., Choi S.H., Baik H.H., Jin B.K., Kim J.H., Chung S.H. Phosphorylation and inactivation of glycogen synthase kinase 3β (GSK3β) by dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A). J. Biol. Chem. 2015, 290:2321-2333.